Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To investigate whether prolonged period of treatment (6 months) can have a better therapeutic
outcome than conventional period (3 months) of antimuscarinics.